These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31348813)

  • 1. Incidence, prevalence and risk factors for hepatitis C in Danish prisons.
    Søholm J; Holm DK; Mössner B; Madsen LW; Hansen JF; Weis N; Sauer AP; Awad T; Christensen PB
    PLoS One; 2019; 14(7):e0220297. PubMed ID: 31348813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low incidence of hepatitis C virus among prisoners in Scotland.
    Taylor A; Munro A; Allen E; Dunleavy K; Cameron S; Miller L; Hickman M
    Addiction; 2013 Jul; 108(7):1296-304. PubMed ID: 23297816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland.
    Stone J; Martin NK; Hickman M; Hutchinson SJ; Aspinall E; Taylor A; Munro A; Dunleavy K; Peters E; Bramley P; Hayes PC; Goldberg DJ; Vickerman P
    Addiction; 2017 Jul; 112(7):1302-1314. PubMed ID: 28257600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs.
    Snow KJ; Young JT; Preen DB; Lennox NG; Kinner SA
    BMC Public Health; 2014 Aug; 14():830. PubMed ID: 25113132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.
    Crowley D; Lambert JS; Betts-Symonds G; Cullen W; Keevans M; Kelly E; Laird E; McHugh T; McKiernan S; Miggin SJ; Murphy C; Murtagh R; O'Reilly D; Tobin C; Van Hout MC
    Euro Surveill; 2019 Apr; 24(14):. PubMed ID: 30968825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects.
    Fiore V; Rastrelli E; Madeddu G; Ranieri R; De Vito A; Giuliani R; Di Mizio G; Bolcato M; De Matteis G; Ialungo AM; Dell'Isola S; Starnini G; Babudieri S
    BMC Infect Dis; 2022 Jul; 22(1):601. PubMed ID: 35799126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.
    Bretaña NA; Gray RR; Cunningham EB; Betz-Stablein B; Ribeiro R; Graw F; Luciani F; Lloyd AR
    Addiction; 2020 May; 115(5):901-913. PubMed ID: 31633853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system.
    Poulin C; Courtemanche Y; Serhir B; Alary M
    Ann Epidemiol; 2018 Apr; 28(4):231-235. PubMed ID: 29576049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test uptake and hepatitis C prevalence in 5483 Danish people in drug use treatment from 1996 to 2015: a registry-based cohort study.
    Øvrehus A; Nielsen S; Hansen JF; Holm DK; Christensen P
    Addiction; 2019 Mar; 114(3):494-503. PubMed ID: 30347471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV testing and treatment initiation in an Italian prison setting: A step-by-step model to micro-eliminate hepatitis C.
    Fiore V; De Matteis G; Ranieri R; Saderi L; Pontali E; Muredda A; Ialungo AM; Caruso R; Madeddu G; Sotgiu G; Babudieri S
    Int J Drug Policy; 2021 Apr; 90():103055. PubMed ID: 33310637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London.
    Aisyah DN; Shallcross L; Hayward A; Aldridge RW; Hemming S; Yates S; Ferenando G; Possas L; Garber E; Watson JM; Geretti AM; McHugh TD; Lipman M; Story A
    J Viral Hepat; 2018 Nov; 25(11):1260-1269. PubMed ID: 29851232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
    Miller ER; Bi P; Ryan P
    Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
    Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
    PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B and hepatitis C infections and their relationship to injectable drug use in a cohort of Sri Lankan prison inmates.
    Niriella MA; Hapangama A; Luke HP; Pathmeswaran A; Kuruppuarachchi KA; de Silva HJ
    Ceylon Med J; 2015 Mar; 60(1):18-20. PubMed ID: 25804913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional study.
    Moradi G; Mohamadi P; Zareie B; Rasouli MA; Gouya MM; Jafari S
    BMC Infect Dis; 2020 Oct; 20(1):806. PubMed ID: 33129259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of 5 years of hepatitis C testing and treatment in the North East of England prisons.
    Johnson A; Shearer J; Thompson C; Jelley R; Aldridge J; Allsop C; Kerry J; Jones D; McCullough F; Miller C; Valappil M; Taha Y; Masson S; Jefferson T; Lawton C; Christensen L; McPherson S
    J Viral Hepat; 2023 Dec; 30(12):914-921. PubMed ID: 37700492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: Implications for prevention and treatment.
    Azbel L; Polonsky M; Wegman M; Shumskaya N; Kurmanalieva A; Asanov A; Wickersham JA; Dvoriak S; Altice FL
    Int J Drug Policy; 2016 Nov; 37():9-20. PubMed ID: 27455177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tattooing in prisons--not such a pretty picture.
    Hellard ME; Aitken CK; Hocking JS
    Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.
    Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J;
    J Viral Hepat; 2017 Sep; 24(9):733-741. PubMed ID: 28256027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
    Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
    Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.